Accessibility Menu
 
Genetic Signatures logo

Genetic Signatures

(ASX) GSS

Current Price$0.09
Market Cap$18.63M
Since IPO (2015)-83%
5 Year-94%
1 Year-79%
1 Month+10%

Genetic Signatures Financials at a Glance

Market Cap

$18.63M

Revenue (TTM)

$30.74M

Net Income (TTM)

$33.86M

EPS (TTM)

$-0.05

P/E Ratio

-1.65

Dividend

$0.00

Beta (Volatility)

-0.06 (Low)

Price

$0.09

Volume

1,140,064

Open

$0.08

Previous Close

$0.09

Daily Range

$0.08 - $0.09

52-Week Range

$0.07 - $0.69

GSS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genetic Signatures

Industry

Life Sciences Tools and Services

CEO

Allison Rossiter

Headquarters

Newtown, NSW 2042, AU

GSS Financials

Key Financial Metrics (TTM)

Gross Margin

-80%

Operating Margin

-1%

Net Income Margin

-70%

Return on Equity

-23%

Return on Capital

-41%

Return on Assets

-23%

Earnings Yield

-60.61%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$18.63M

Shares Outstanding

227.14M

Volume

1.14M

Avg. Volume

737.82K

Financials (TTM)

Gross Profit

$7.78M

Operating Income

$18.48M

EBITDA

$16.08M

Operating Cash Flow

$12.29M

Capital Expenditure

$902.00K

Free Cash Flow

$13.19M

Cash & ST Invst.

$31.30M

Total Debt

$791.00K

Genetic Signatures Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$8.68M

+140.9%

Gross Profit

$6.61M

+30.0%

Gross Margin

-76.14%

N/A

Market Cap

$18.63M

N/A

Market Cap/Employee

$159.19K

N/A

Employees

117

N/A

Net Income

$6.37M

+39.2%

EBITDA

$7.78M

+30.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$29.22M

+61.3%

Accounts Receivable

$4.55M

+25.5%

Inventory

$8.54M

+5.4%

Long Term Debt

$188.00K

N/A

Short Term Debt

$465.00K

+3775.0%

Return on Assets

-22.98%

N/A

Return on Invested Capital

-40.89%

N/A

Free Cash Flow

$948.00K

+83.4%

Operating Cash Flow

$349.00K

+85.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPD.AXImpediMed Limited
$0.01+0.00%
BMT.AXBeamtree Holdings Limited
$0.12+0.00%
MX1.AXMicro-X Limited
$0.05+0.00%
MVP.AXMedical Developments International Limited
$0.47+7.95%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.29+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About GSS

What is the current price of Genetic Signatures?

Genetic Signatures is trading at A$0.09 per share.

What is the 52-week range for Genetic Signatures?

Over the past 52 weeks, Genetic Signatures has traded between A$0.07 and A$0.69.

How much debt does Genetic Signatures have?

As of the most recent reporting period, Genetic Signatures reported total debt of $791,000.

How much cash does Genetic Signatures have on hand?

Genetic Signatures reported $7.47M in cash and cash equivalents in its most recent financial results.

What is Genetic Signatures’s dividend yield?

Genetic Signatures does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.